Tranquil Clinical Research
Clinical research organization focused on early‑phase and full‑service CRO support, including a hospital‑based Phase I unit. Services span study start‑up through closeout, sponsor oversight/CRO oversight, data management, regulatory support, pharmacovigilance, and patient recruitment. Operates a Functional Service Provider model for CRA staffing, training and monitoring support.
Industries
Nr. of Employees
small (1-50)
Tranquil Clinical Research
16969 N Texas Ave Suite 600, Webster, TX 77598
Products
Full-Service CRO
Provides comprehensive clinical research organization services managing clinical trial operations from study startup to closeout.
Phase I Unit Services
Hospital-based clinical trial services focused on early-phase, first-in-human studies.
Triumph Functional Service Provider (FSP)
Delivers functional service provider solutions including clinical research associate staffing and oversight for clinical trials.
Clinical Trial Monitoring
Monitors clinical trial conduct to ensure compliance with protocols and regulatory requirements.
Study Start-up Services
Manages the initiation phase of clinical trials including regulatory submissions and site activation.
Study Rescue Services
Intervenes in troubled clinical trials to address issues and bring studies back on track.
Full-Service CRO
Provides comprehensive clinical research organization services managing clinical trial operations from study startup to closeout.
Phase I Unit Services
Hospital-based clinical trial services focused on early-phase, first-in-human studies.
Triumph Functional Service Provider (FSP)
Delivers functional service provider solutions including clinical research associate staffing and oversight for clinical trials.
Clinical Trial Monitoring
Monitors clinical trial conduct to ensure compliance with protocols and regulatory requirements.
Study Start-up Services
Manages the initiation phase of clinical trials including regulatory submissions and site activation.
Study Rescue Services
Intervenes in troubled clinical trials to address issues and bring studies back on track.
Services
Monitoring services delivered on‑site, remote, centralized or decentralized to oversee protocol adherence and data integrity.
Complete data management services including EDC to support study dataset capture and quality.
Clinical safety oversight and pharmacovigilance services to monitor and report adverse events.
Services to support pre‑clinical stage activities and prepare programs for clinical transition.
Full clinical project management covering planning, execution, and oversight.
Support for global regulatory law interpretation, filings and agency interactions.
Monitoring services delivered on‑site, remote, centralized or decentralized to oversee protocol adherence and data integrity.
Complete data management services including EDC to support study dataset capture and quality.
Clinical safety oversight and pharmacovigilance services to monitor and report adverse events.
Services to support pre‑clinical stage activities and prepare programs for clinical transition.
Full clinical project management covering planning, execution, and oversight.
Support for global regulatory law interpretation, filings and agency interactions.
Expertise Areas
- Clinical trial management
- Early‑phase / Phase I unit operations
- Sponsor oversight and CRO governance
- Patient recruitment and retention
Key Technologies
- Electronic data capture (EDC) systems
- Remote monitoring and decentralized trial methods
- Clinical trial metrics and QC reporting
- Protocol development and regulatory submission workflows
News & Updates
Attendance at industry conferences to engage with biotech and pharma leaders and stay current on industry developments.
Guidance and processes for safely starting clinical trials remotely during the COVID‑19 pandemic.
Company event to bring together industry leaders and stakeholders for collaboration and knowledge exchange.
Served as full‑service CRO conducting protocol development, FDA submissions/approvals, pharmacovigilance, clinical project management and operations for a Phase II COVID trial.
Selected to enroll 200 subjects on a device collection trial and enrolled all 200 subjects (35% minority enrollment) within 10 business days.
Induction of the company's founder and CEO into a biographical registry recognizing professional achievements.
Attendance at industry conferences to engage with biotech and pharma leaders and stay current on industry developments.
Guidance and processes for safely starting clinical trials remotely during the COVID‑19 pandemic.
Company event to bring together industry leaders and stakeholders for collaboration and knowledge exchange.
Served as full‑service CRO conducting protocol development, FDA submissions/approvals, pharmacovigilance, clinical project management and operations for a Phase II COVID trial.
Selected to enroll 200 subjects on a device collection trial and enrolled all 200 subjects (35% minority enrollment) within 10 business days.
Induction of the company's founder and CEO into a biographical registry recognizing professional achievements.